Quang X. Pham - Jan 23, 2025 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Signature
/s/ Matthew K. Szot, Attorney-in-fact
Stock symbol
CVKD
Transactions as of
Jan 23, 2025
Transactions value $
$0
Form type
4
Date filed
1/24/2025, 06:10 PM
Previous filing
Apr 10, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of options to purchase 65,000 shares of common stock, which shall vest 1/4 on February 1, 2026 and thereafter pro rata on a monthly basis over three years, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to 110% of the fair market value of the Issuer's common stock on the effective date of the grant.